Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 5
Submit an article Journal homepage
184
Views
6
CrossRef citations to date
0
Altmetric
Letters to the Editor

BCR-ABL1 positive lymphoblastic lymphoma – should it be treated like a B-lymphoblastic leukemia with t(9;22);BCR-ABL1?

Taro TakahashiDepartment of Hematology, Osaki Citizen Hospital, Osaki, Japan; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-5434-2407
ORCID Icon,
Satoshi IchikawaDepartment of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan;
,
Ryo IchinohasamaDepartment of Hematopathology, Tohoku University Graduate School of Medicine, Sendai, Japan
&
Hideo HarigaeDepartment of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan;
Pages 1265-1267 | Received 27 Aug 2019, Accepted 10 Dec 2019, Published online: 26 Dec 2019

References

  • Cortelazzo S, Ferreri A, Hoelzer D, et al. Lymphoblastic lymphoma. Crit Rev Oncol Hematol. 2017;113:304–317.
  • Sadrzadeh H, Huck AE, Chen YB, et al. Philadelphia chromosome positive B-cell lymphoblastic lymphoma isolated to bone. Leuk Lymphoma. 2013;54:2052–2054.
  • Zhu J, Zhang S, Zhu L, et al. Primary testicular Ph-positive B lymphoblastic lymphoma:an unusual presentation and review. Cancer Biol Ther. 2015;16:1122–1127.
  • Boddu P, Yin C, Kanagal-Shamanna R, et al. An unsuspected finding of t(9;22): a rare case of philadelphia chromosome-positive b-lymphoblastic lymphoma. Case Report Hematol. 2017;2017:1–4.
  • Alshomar A, Fakih RE. Philadelphia chromosome-positive lymphoblastic lymphoma-Is it rare or under diagnosed? Hematol Oncol Stem Cell Ther. 2018. DOI:10.1016/j.hemonc.2018.05.007
  • Harrison CJ. Targeting signaling pathways in acute lymphoblastic leukemia:new insights. ASH Hematol Educ Program. 2013;2013(1):118–125.
  • Lin P, Jones D, Dorfman DM, et al. Precursor B-cell Lymphoblastic Lymphoma. Am J Surg Pathol. 2000;24(11):1480–1490.
  • Short NJ, Jabbour E, Sasaki K, et al. Impact of complete molecular response on survival in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood. 2016;128(4):504–507.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.